Chapter 607 Autonomic Neuropathies
The differential diagnosis is noted in Table 607-1. Autonomic nervous system functional tests are noted in Table 607-2. The general treatment of acquired autonomic dysfunction includes treating the primary disorder (systemic lupus erythematosus, diabetes) and long-term management of specific organ system manifestations (Table 607-3). Acute fluctuations of autonomic symptoms may be seen in Guillain-Barré syndrome. Rapid fluctuations of hypertension or tachycardia changing to hypotension or bradycardia should be managed carefully and with very short-acting medications.
Table 607-2 AUTONOMIC FUNCTION TESTING
Sympathetic and parasympathetic divisions of the autonomic nervous system are involved in all tests of autonomic function
CARDIAC PARASYMPATHETIC NERVOUS SYSTEM FUNCTION
SYMPATHETIC ADRENERGIC FUNCTION
SYMPATHETIC CHOLINERGIC FUNCTION
From Freeman R: Autonomic peripheral neuropathy, Lancet 365:1259–1270, 2005.
Table 607-3 MANAGEMENT OF AUTONOMIC NEUROPATHIES
PROBLEM | TREATMENT |
---|---|
Orthostatic hypotension | |
Gastroparesis | Prokinetic agents (metaclopramide, domperidone, erythromycin) |
Hypomotility | Fiber, laxatives |
Urinary dysfunction | Timed voiding; bladder catheterization |
Hyperhidrosis |
607.1 Familial Dysautonomia
Anderson SL, Qiu J, Rubin BY. Tocotrienols induce IKBKAP expression: a possible therapy for familial dysautonomia. Biochem Biohys Res Commun. 2003;306:303-309.
Axelrod FB. Familial dysautonomia. Muscle Nerve. 2004;29:352-363.
Freeman R. Autonomic peripheral neuropathy. Lancet. 2005;365:1259-1270.
Gold-Von Simson G, Rutkowski M, Berlin D, et al. Pacemakers in patients with familial dysautonomia—a review of experience with 20 patients. Clin Autonom Res. 2005;15:15-20.
Kamboj MK, Axelrod FG, David R, et al. Growth hormone treatment in children with familial dysautonomia. J Pediatr. 2004;144:63-67.
Lerner BH. When diseases disappear—the case of familial dysautonomia. N Engl J Med. 2009;361:1622-1625.
Rubin BY, Anderson SL. The molecular basis of familial dysautonomia: overview, new discoveries and implications for directed therapies. Neuromol Med. 2008;10:148-156.
607.2 Other Autonomic Neuropathies
Myenteric Plexus Neuropathies
Aganglionic megacolon (Hirschsprung disease) is a failure of embryonic development of parasympathetic neurons in the submucosal and myenteric plexuses of segments of the colon and rectum. Nerves between the longitudinal and circular layers of smooth muscle of the gut wall are hypertrophic; ganglion cells are absent (Chapter 324).
Congenital Insensitivity to Pain and Anhidrosis
Congenital insensitivity to pain and anhidrosis is a hereditary disorder of uncertain genetic transmission. It affects many more boys than girls and manifests in early infancy. Patients have episodes of high fever related to warm environmental temperatures because they do not perspire. Frequent burns and traumatic injuries result from apparent lack of pain perception. Intelligence is normal. Nerve biopsy reveals an almost total absence of unmyelinated nerve fibers that convey impulses of pain, temperature, and autonomic functions. Some cases of hypomyelinating neuropathy manifest clinically as congenital insensitivity to pain (Chapter 605.8). The sympathetic skin response as an electrophysiologic study is a reliable diagnostic test in cases associated with a mutation at the TrKA receptor for nerve growth factor.
Reflex Sympathetic Dystrophy
Reflex sympathetic dystrophy is a form of local causalgia, usually involving a hand or foot but not corresponding to the anatomic distribution of a peripheral nerve (Chapter 162.2). A continuous burning pain and hyperesthesia are associated with vasomotor instability in the affected zone, resulting in increased skin temperature, erythema, and edema due to vasodilatation and hyperhidrosis. In the chronic state, atrophy of skin appendages, cool and clammy skin, and disuse atrophy of underlying muscle and bone occur. More than 1 extremity is occasionally involved. The pain is disabling and is exacerbated by the movement of an associated joint, although no objective signs of arthritis are seen; immobilization provides some relief. The most common preceding event is local trauma in the form of a contusion, laceration, sprain, or fracture that occurred days or weeks earlier.
Gold-Von Simson G, Goldberg JD, Rolnitzky LM, et al. Kinetin in familial dysautonomia carriers: implication for a new therapeutic strategy targeting mRNA splicing. Pediatr Res. 2009;65:341-346.
Kurth I, Pamminger T, Hennings JC, et al. Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy. Nature Genetics. 2009;41:1179-1181.